Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Asset Utilization Ratio: 2021-2025

Historic Asset Utilization Ratio for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to 0.71.

  • Journey Medical's Asset Utilization Ratio fell 20.12% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year decrease of 20.12%. This contributed to the annual value of 0.71 for FY2024, which is 17.86% down from last year.
  • As of Q3 2025, Journey Medical's Asset Utilization Ratio stood at 0.71, which was up 5.18% from 0.68 recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Asset Utilization Ratio ranged from a high of 1.18 in Q2 2024 and a low of 0.62 during Q1 2023.
  • For the 3-year period, Journey Medical's Asset Utilization Ratio averaged around 0.88, with its median value being 0.78 (2024).
  • In the last 5 years, Journey Medical's Asset Utilization Ratio spiked by 79.15% in 2024 and then slumped by 42.42% in 2025.
  • Over the past 5 years, Journey Medical's Asset Utilization Ratio (Quarterly) stood at 0.68 in 2021, then grew by 1.94% to 0.69 in 2022, then surged by 60.59% to 1.11 in 2023, then dropped by 29.85% to 0.78 in 2024, then decreased by 20.12% to 0.71 in 2025.
  • Its Asset Utilization Ratio stands at 0.71 for Q3 2025, versus 0.68 for Q2 2025 and 0.68 for Q1 2025.